- Conditions
- Nocturia, Hypertension, Sleep Disturbance
- Interventions
- BBTI, PM antihypertensive dosing or Chronotherapy, AM antihypertensive dosing
- Behavioral · Other
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Dec 16, 2024 · Synced May 21, 2026, 9:44 PM EDT